Intuitive Surgical (ISRG) Income from Non-Controlling Interests (2017 - 2026)
Intuitive Surgical's (ISRG) quarterly Income from Non-Controlling Interests came in at -$18.7 million in Q2 2026, down 422.41% year-on-year from $5.8 million in Q2 2025, and up 20.76% quarter-over-quarter from -$23.6 million in Q1 2026.
Intuitive Surgical (ISRG) Income from Non-Controlling Interests (2017 - 2026) Analysis & Trends
Intuitive Surgical's Income from Non-Controlling Interests history runs 10 years deep, the most recent figure standing at -$18.7 million for Q2 2026.
- On a quarterly basis, Income from Non-Controlling Interests fell 422.41% year-over-year to -$18.7 million in Q2 2026; TTM through Jun 2026 was -$58.4 million, a 335.48% decrease from a year earlier, with the FY2025 full-year figure at $20.6 million, up 38.26% from the prior year.
- Income from Non-Controlling Interests grew to -$18.7 million in Q2 2026 per ISRG's latest filing, from -$23.6 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $59.5 million in Q3 2024 and bottomed at -$90.7 million in Q1 2022.
- The 5-year median for Income from Non-Controlling Interests is $4.1 million (2023), against an average of -$6.9 million.
- Biggest YoY gain for Income from Non-Controlling Interests was 1351.22% in 2024; the steepest drop was 1120.0% in 2024.
- Year by year, Income from Non-Controlling Interests stood at $13.9 million in 2022, then plunged by 67.63% to $4.5 million in 2023, then tumbled by 1120.0% to -$45.9 million in 2024, then surged by 54.03% to -$21.1 million in 2025, then grew by 11.37% to -$18.7 million in 2026.
- Per Business Quant, the three latest ISRG Income from Non-Controlling Interests figures stand at -$18.7 million (Q2 2026), -$23.6 million (Q1 2026), and -$21.1 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.93 Bn | 121.71 Bn | 1.96 Bn | -18.70 Mn |
| 2 | Becton Dickinson | 44.94 Bn | 44.13 Bn | 2.15 Bn | - |
| 3 | Alcon | 33.13 Bn | 31.47 Bn | 1.53 Bn | - |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn | 110.00 Mn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.28 Bn | 22.84 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.11 Bn | 13.55 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.80 Bn | 13.66 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn | - |
| 10 | Baxter International | 11.95 Bn | 9.93 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.70 Mn |
| Mar 31, 2026 | -23.60 Mn |
| Dec 31, 2025 | -21.10 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 5.80 Mn |
| Mar 31, 2025 | 5.40 Mn |
| Dec 31, 2024 | -45.90 Mn |
| Sep 30, 2024 | 59.50 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | -4.20 Mn |
| Dec 31, 2023 | 4.50 Mn |
| Sep 30, 2023 | 4.10 Mn |
| Jun 30, 2023 | 4.10 Mn |
| Mar 31, 2023 | 5.50 Mn |
| Dec 31, 2022 | 13.90 Mn |
| Sep 30, 2022 | 700,000.00 |
| Jun 30, 2022 | -33.40 Mn |
| Mar 31, 2022 | -90.70 Mn |
| Dec 31, 2021 | 2.50 Mn |
| Sep 30, 2021 | 6.60 Mn |